Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like Dropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz April 25, 2017 Teva CEO Says 2018 Will Be a Year of Falling Sales and Profits February 8, 2018 Bristol-Myers, Johnson & Johnson Get in on Europeon Biotech Fund's $95M Raise October 30, 2017
